Jonathan Rubin Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity

Jonathan Rubin is SVP, Chief Medical Officer of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 4,641 shares of SUPN, which is worth approximately $169,907. The most recent transaction as insider was on Feb 23, 2024, when has been sold 567 shares (Common Stock) at a price of $29.06 per share, resulting in proceeds of $16,477. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.64K

0% 3M change

85.86% 12M change

Total Value Held $169,907

Jonathan Rubin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 23 2024	SELL Payment of exercise price or tax liability	$16,477 $29.06 p/Share	567 Reduced 10.89%	4,641 Common Stock
Feb 23 2024	BUY Grant, award, or other acquisition	-	1,250 Added 19.36%	5,208 Common Stock
Feb 22 2024	SELL Payment of exercise price or tax liability	$8,465 $27.94 p/Share	303 Reduced 7.11%	3,958 Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	750 Added 14.97%	4,261 Common Stock
Dec 22 2023	SELL Payment of exercise price or tax liability	$5,642 $27.66 p/Share	204 Reduced 5.92%	3,243 Common Stock
Dec 22 2023	BUY Exercise of conversion of derivative security	-	600 Added 14.83%	3,447 Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	750 Added 23.1%	2,497 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	1,500 Added 50.0%	1,500 Common Stock

Jonathan Rubin

SVP, Chief Medical Officer

Rockville, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Value

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

Operation

Value

Type

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Track Activities on SUPN

Account